Previous study revealed that
bufalin can inhibit proliferation, and induce apoptosis in some human
cancer cell lines. However, the mechanism of its anticancer effect has not been fully understood. The present study was designed to investigate the effects of
bufalin-induced apoptosis on Bcl-2 and PKC in human leukemic HL-60 cells. The cell viability was determined by
trypan blue dye exclusion. The apoptosis was detected by morphology, flow cytometry and
DNA agarose gel electrophoresis. The expressions of Bcl-2 and PKC were analyzed by Western blot, and activity of PKC was assayed by [gamma-(32)P]
isotope incorporation method. The results showed as follows: (1) proliferation of HL-60 cells was inhibited by
bufalin and the IC(50) at 24, 48, 72 hours were (25.8 +/- 2.1), (8.0 +/- 1.2) and (2.3 +/- 0.3) nmol/L, respectively. (2) apoptosis of HL-60 cells was induced when the cells were treated with
bufalin at concentration of 50 nmol/L for 24 hours. (3) compared with control, treatment with
bufalin at concentration of 50 nmol/L for 6 - 24 hours resulted in downregulation of
protein expression, decrease of phosphorylation, and cleavage of Bcl-2, simultaneously. (4) the activity of total PKC was unchanged when HL-60 cells were exposed to 1 - 100 nmol/L
bufalin for 30 minutes, but PKCbetaII underwent translocation from cytosol to membrane. It is concluded that apoptosis induced by
bufalin is associated with downregulation of
protein expression, dephosphorylation, and cleavage of Bcl-2 in HL-60 cells.